喘息発作とホルモン避妊薬の関係(Asthma attacks more common for some women taking the progesterone-only pill)

ad

2025-05-07 インペリアル・カレッジ・ロンドン(ICL)

インペリアル・カレッジ・ロンドンの研究によると、プロゲステロン単独の経口避妊薬「ミニピル」の使用は、一部の女性で喘息発作のリスクを増加させる可能性がある。約26万人の女性を対象とした調査で、35歳未満の使用者では発作リスクが39%高まり、好酸球性喘息患者では24%の増加が確認された。一方、エストロゲンを含む複合避妊薬ではその傾向は見られなかった。この結果は、性ホルモンが喘息に与える影響を示唆しており、今後の治療方針や避妊薬の選択に影響を与える可能性がある。

<関連情報>

経口避妊薬と喘息発作のリスク:集団ベースのコホート研究 Oral contraceptives and the risk of asthma attacks: a population-based cohort study

Bohee Lee,Rafati Fard Amir Reza,Ernie Wong,…
ERJ Open Research  Published:24 April 2025
DOI:https://doi.org/10.1183/23120541.01278-2024

Abstract

Background

The role that sex hormones play in asthma remains unclear. The oral contraceptive pill (OCP), commonly used by younger women, acutely increases sex hormones providing an opportunity to observe their effect.

Objective

Evaluate the association between OCP and asthma attacks.

Methods

Using the UK’s Clinical Practice Research Datalink, linked to hospital admission and mortality data, 2004 to 2020, we observed women with asthma (18–50 years), comparing OCP never-users to new-users; separated into a combined oral contraceptive (COC) cohort and progestogen-only (POP) cohort. We applied inverse-probability of treatment weighting and Cox proportional hazards, accounting for demographics, asthma severity/control and comorbidities. Additionally, we stratified by potential modifiers: age, BMI, blood eosinophils (x109 cells·L-1, normal <0.3, eosinophilia ≥0.3) and corticosteroid use (lower use: ≤3 inhaled corticosteroids prescriptions, higher use: ≥4 inhaled and/or oral corticosteroids).

Results

132 676 and 129 151 were eligible for the COC and POP cohorts, respectively. There was no association between COC, or POP, and asthma attacks (weighted-HR, 95% CI: COC=1.00, 0.89–1.13; POP=1.11, 0.97–1.28). However, POP association was modified by asthma phenotype and corticosteroid use, but not BMI, after accounting for asthma severity/control, demographics and comorbidities. In the POP users, women who were younger than 35 years old (1.39, 1.12–1.72), those with eosinophilia (1.24, 0.97–1.58), or those with lower corticosteroid use (1.20, 1.03–1.40) had an elevated risk of asthma attacks.

Conclusions

Commencing exogenous progesterone without an estrogen component (POP) was associated with increased asthma attacks in asthma phenotypes including in younger women, eosinophilic-asthma, and women with lower corticosteroid use.

 

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました